Cubist Systematic Strategies, LLC Cytom X Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 24,460 shares of CTMX stock, worth $25,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,460

Previous 82,054 70.19%

Holding current value

$25,927

Previous $100,000 72.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.12 - $1.51 $64,505 - $86,966	-57,594 Reduced 70.19%	24,460 $28,000
Q2 2024 Aug 14, 2024	BUY	$1.21 - $5.13 $48,773 - $206,785	40,309 Added 96.56%	82,054 $100,000
Q1 2024 May 15, 2024	BUY	$1.41 - $2.74 $58,860 - $114,381	41,745 New	41,745 $91,000
Q3 2021 Nov 15, 2021	SELL	$4.32 - $6.43 $691 - $1,028	-160 Reduced 1.68%	9,346 $48,000
Q1 2021 May 17, 2021	SELL	$6.6 - $9.0 $187,050 - $255,069	-28,341 Reduced 74.88%	9,506 $73,000
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $89,305 - $109,043	13,803 Added 57.41%	37,847 $248,000
Q3 2020 Nov 16, 2020	BUY	$6.55 - $8.83 $116,321 - $156,811	17,759 Added 282.56%	24,044 $160,000
Q2 2020 Aug 14, 2020	SELL	$7.4 - $14.64 $54,545 - $107,911	-7,371 Reduced 53.98%	6,285 $52,000
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $25 - $60	7 Added 0.05%	13,656 $105,000
Q4 2019 Feb 14, 2020	BUY	$5.17 - $8.91 $70,565 - $121,612	13,649 New	13,649 $113,000
Q3 2019 Nov 14, 2019	SELL	$7.38 - $12.25 $345,229 - $573,042	-46,779 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.35 - $11.41 $295,469 - $360,567	31,601 Added 208.2%	46,779 $525,000
Q1 2019 May 15, 2019	SELL	$9.5 - $19.16 $225,796 - $455,394	-23,768 Reduced 61.03%	15,178 $163,000
Q4 2018 Feb 14, 2019	BUY	$12.69 - $18.61 $177,951 - $260,968	14,023 Added 56.27%	38,946 $588,000
Q3 2018 Nov 14, 2018	BUY	$18.04 - $26.41 $299,427 - $438,353	16,598 Added 199.38%	24,923 $461,000
Q2 2018 Aug 14, 2018	SELL	$21.38 - $29.68 $272,680 - $378,538	-12,754 Reduced 60.51%	8,325 $190,000
Q1 2018 May 15, 2018	SELL	$21.76 - $34.22 $122,900 - $193,274	-5,648 Reduced 21.13%	21,079 $600,000
Q4 2017 Feb 14, 2018	BUY	$19.0 - $23.09 $507,813 - $617,126	26,727	26,727 $564,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Cytom X Therapeutics, Inc. Transaction History